GlassScriptPhysician profile
Mike K Liang
NPI 1942374178
$7,150.22
in general payments reported to CMS, 2019-2025
28 companies · $403 in 2025
The $403 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $898 · 2020: $352 · 2021: $3,185 · 2022: $566 · 2023: $897 · 2024: $851 · 2025: $403.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,107 · Education: $43.94.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,106.92 |
| Education | $43.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $3,253.83 | 2019-2024 | Da Vinci Surgical System |
| Ethicon US, LLC | $819.33 | 2019-2025 | Echelon Flex, Enseal, Echelon; Endopath |
| Davol INC. | $636.53 | 2019-2023 | Phasix Mesh |
| Integra Lifesciences Corporation | $578.91 | 2021-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Allergan, INC. | $223.78 | 2019-2020 | |
| Kls-Martin L.P. | $196.18 | 2021-2024 | |
| Abbott Laboratories | $154.28 | 2024 | Proclaim |
| Medtronic, INC. | $130.22 | 2021-2025 | Aquamantys(Tm), Parietex |
| Smith+Nephew, INC. | $126.99 | 2022-2025 | Pico 7, Collagenase Santyl |
| Covidien LP | $105.60 | 2019 | |
| Acell, INC. | $99.70 | 2019-2020 | |
| Aroa Biosurgery Incorporated | $97.97 | 2024-2025 | |
| Teleflex LLC | $86.55 | 2022-2023 | Quikclot |
| Depuy Synthes Sales INC. | $86.00 | 2022 | |
| Kci USA, INC. | $74.64 | 2019-2023 | V.A.C. Veraflo, 3m Cavilon, Prevena |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kerecis Limited | $67.14 | 2022-2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Takeda Pharmaceuticals U.S.A., INC. | $57.46 | 2020-2023 | Gattex |
| Tela Bio, INC. | $54.86 | 2023-2024 | Ovitex 2s, Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Janssen Pharmaceuticals, INC | $43.23 | 2019 | |
| Stryker Corporation | $43.15 | 2024 | 1788 |
| Haemonetics Corporation | $42.27 | 2022 | |
| Medinc of Texas | $34.67 | 2025 | |
| Polynovo North America LLC | $30.20 | 2024 | Novosorb Btm |
| Solventum Corporation | $27.42 | 2025 | Abthera, Prevena, V.A.C.Instill |
| Silk Road Medical, INC. | $27.08 | 2023 | Enroute Transcarotid Stent, Enroute Transcarotid Neuroprotection System |
| Tetraphase Pharmaceuticals, INC. | $23.07 | 2019 | |
| Convatec INC. | $15.90 | 2019 | |
| Angiodynamics, INC. | $13.26 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mike Liang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.